removal-trace-elements-cupric-oxide-nanoparticles-from-uranium-situ

Removal of Trace Elements by Cupric Oxide Nanoparticles from Uranium <em>In Situ</em> Recovery Bleed Water and Its Effect on Cell Viability

In situ recovery (ISR) is the predominant method of uranium extraction in the United States. During ISR, uranium is leached from an ore body and extracted ...

University of Wyoming

Impact of a workplace health and wellness pharmaceutical care service on the weight and obesity classification of employees.

To determine if propylene glycol accumulates in children receiving continuous lorazepam infusion and, if accumulation occurs, to determine if it is associated with significant laboratory abnormalities.

Propylene glycol accumulation associated with continuous infusion of lorazepam in pediatric intensive care patients.

To identify the effectiveness of adherence interventions reported in the literature, to identify interventions being conducted and/or sponsored by large chain pharmacies and pharmaceutical manufacturers, and to seek input from a panel of pharmacists who address adherence issues on a daily basis as to the steps that should be taken to advance a national initiative to increase awareness of the importance of and opportunities associated with medication adherence and persistence.

Improving adherence and persistence: a review and assessment of interventions and description of steps toward a national adherence initiative.

Estimates of adherence to long-term medication regimens range from 17% to 80%, and nonadherence (or nonpersistence) can lead to increased morbidity, mortality, and healthcare costs. Multifaceted interventions that target specific barriers to adherence are most effective, because they address the problems and reinforce positive behaviors. Providers must assess their patients' understanding of the illness and its treatment, communicate the benefits of the treatment, assess their patients' readiness to carry out the treatment plan, and discuss any barriers or obstacles to adherence that patients may have. A positive, supporting, and trusting relationship between patient and provider improves adherence. Individual patient factors also affect adherence. For example, conditions that impair cognition have a negative impact on adherence. Other factors--such as the lack of a support network, limited English proficiency, inability to obtain and pay for medications, or severe adverse effects or the fear of such effects--are all barriers to adherence. There are multiple reasons for nonadherence or nonpersistence; the solution needs to be tailored to the individual patient's needs. To have an impact on adherence, healthcare providers must understand the barriers to adherence and the methods or tools needed to overcome them. This report describes the barriers to medication adherence and persistence and interventions that have been used to address them; it also identifies interventions and compliance aids that practitioners and organizations can implement.

Medication adherence and persistence: a comprehensive review.

Obesity, a national epidemic, is one of the leading causes of preventable morbidity and mortality in the US. Pharmacists can play an integral role in weight management. Offering weight management services provides an opportunity to increase public awareness of pharmaceutical care and attract patients to pharmacy programs.

Implementation of a weight management pharmaceutical care service.

L&#39;ob&eacute;sit&eacute;, une &eacute;pid&eacute;mie nationale, est l&#39;une des principales causes de morbidit&eacute; &eacute;vitable et de mortalit&eacute; aux Etats-Unis. Pharmaciens peuvent jouer un r&ocirc;le essentiel dans la gestion du poids. Offrant des services de gestion de poids fournit l&#39;occasion de sensibiliser le public des soins pharmaceutiques et attirer les patients &agrave; des programmes de pharmacie.

Mise en place d&#39;un service de soins pharmaceutiques de gestion de poids.

L&#39;obesit&agrave;, un&#39;epidemia nazionale, &egrave; una delle principali cause di morbilit&agrave; prevenibile e mortalit&agrave; negli Stati Uniti. I farmacisti possono svolgere un ruolo fondamentale nella gestione del peso corporeo. Peso gestione servizi offre l&#39;opportunit&agrave; di aumentare la sensibilizzazione del pubblico di assistenza farmaceutica e attrarre pazienti ai programmi della farmacia.

Implementazione di un servizio di assistenza farmaceutica management di peso.

Obesidad, una epidemia nacional, es una de las principales causas de morbimortalidad evitable en los Estados Unidos. Farmac&eacute;uticos pueden desempe&ntilde;ar un papel integral en el manejo del peso. Peso management services ofrece una oportunidad para aumentar la conciencia p&uacute;blica de la atenci&oacute;n farmac&eacute;utica y atraer a pacientes a programas de farmacia.

Implementaci&oacute;n de un servicio de atenci&oacute;n farmac&eacute;utica de la gesti&oacute;n de peso.

The literature describing pharmacists' use of personal digital assistants (PDAs) as intervention documentation tools in health systems is reviewed.

Use of personal digital assistants for documentation of pharmacists' interventions: a literature review.

To incorporate Fink's Taxonomy of Significant Learning into a course and determine whether doing so increased students' knowledge of and interest in healthcare policy.

A health policy course based on Fink's Taxonomy of Significant Learning.

Invasive aspergillosis is a life-threatening fungal infection predominately affecting immunocompromised individuals. The incidence of inpatient-treated aspergillosis cases in the US is estimated to be between 3.02 and 3.80 per 10,000 hospitalized patients. The estimated difference in hospital costs of patients with an aspergillosis infection is US$36,867 to US$59,356 higher than those of patients without the infection. Voriconazole is a synthetic, broad spectrum triazole antifungal agent, with FDA-approved indications for the treatment of invasive aspergillosis, esophageal candidiasis, candidemia in nonneutropenic patients, invasive candidiasis, and infections due to Scedosporium apiospermum and Fusarium species in patients refractory to or intolerant of other therapy. Eight cost-effectiveness analyses, one cost-minimization analysis, and one cost analysis were identified from a Medline search. The 10 pharmacoeconomic analyses were conducted in six different countries comparing voriconazole to conventional amphotericin B, liposomal amphotericin B, itraconazole, and caspofungin. All the cost-effectiveness and cost-minimization analyses identified voriconazole as the most cost-effective therapy. The cost analysis demonstrated voriconazole cost-savings. While the acquisition costs of voriconazole are higher than those of conventional amphotericin B, the toxicity profile and rate of treatment success associated with voriconazole result in lower total treatment costs per successfully treated patient.

Economic considerations in the treatment of invasive aspergillosis: a review of voriconazole pharmacoeconomic studies.

The purpose of this study was to determine if the number of red blood cell (RBC) transfusions anemic pediatric intensive care unit patients receive could be reduced by the prophylactic administration of recombinant human erythropoietin (rHuEPO).

Prospective randomized double-blind placebo controlled trial of recombinant human erythropoietin administration to reduce blood transfusions in anemic pediatric intensive care patients.

Article	Year
Impact of a workplace health and wellness pharmaceutical care service on the weight and obesity classification of employees. Journal of the American Pharmaceutical Association (Washington,D.C. : 1996)\| PubMed ID: 11833503	2002
Propylene glycol accumulation associated with continuous infusion of lorazepam in pediatric intensive care patients. Critical care medicine\| PubMed ID: 12483068	2002
Improving adherence and persistence: a review and assessment of interventions and description of steps toward a national adherence initiative. Journal of the American Pharmacists Association : JAPhA\| PubMed ID: 14717263	2003
Medication adherence and persistence: a comprehensive review. Advances in therapy\| PubMed ID: 16418141	2005
Implementation of a weight management pharmaceutical care service. The Annals of pharmacotherapy\| PubMed ID: 17284503	2007
Use of personal digital assistants for documentation of pharmacists' interventions: a literature review. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists\| PubMed ID: 17617503	2007
A health policy course based on Fink's Taxonomy of Significant Learning. American journal of pharmaceutical education\| PubMed ID: 21451768	2011
Economic considerations in the treatment of invasive aspergillosis: a review of voriconazole pharmacoeconomic studies. ClinicoEconomics and outcomes research : CEOR\| PubMed ID: 21935305	2009
Prospective randomized double-blind placebo controlled trial of recombinant human erythropoietin administration to reduce blood transfusions in anemic pediatric intensive care patients. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG\| PubMed ID: 23118648	2006

Kem P. Krueger

Biography

JoVE Journal Publications

Other Publications